Studying the Safety and Determining the Optimal Dose of Novobiocin in Patients With Tumors That Have Alterations in DNA Repair Genes

RECRUITING

Laura and Isaac Perlmutter Cancer Center at NYU Langone, New York

RECRUITING

NYU Langone Hospital - Long Island, Mineola

RECRUITING

National Cancer Institute Developmental Therapeutics Clinic, Bethesda

ACTIVE_NOT_RECRUITING

National Institutes of Health Clinical Center, Bethesda

RECRUITING

Ohio State University Comprehensive Cancer Center, Columbus

RECRUITING

University of Wisconsin Carbone Cancer Center - Eastpark Medical Center, Madison

RECRUITING

University of Wisconsin Carbone Cancer Center - University Hospital, Madison

RECRUITING

University of Chicago Comprehensive Cancer Center, Chicago

RECRUITING

University of Oklahoma Health Sciences Center, Oklahoma City

RECRUITING

Huntsman Cancer Institute/University of Utah, Salt Lake City

RECRUITING

Los Angeles General Medical Center, Los Angeles

RECRUITING

USC / Norris Comprehensive Cancer Center, Los Angeles

RECRUITING

City of Hope Comprehensive Cancer Center, Duarte

RECRUITING

UC San Diego Moores Cancer Center, La Jolla

RECRUITING

UC San Diego Medical Center - Hillcrest, San Diego

RECRUITING

UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care, Irvine

RECRUITING

UC Irvine Health/Chao Family Comprehensive Cancer Center, Orange

RECRUITING

University of California Davis Comprehensive Cancer Center, Sacramento

RECRUITING

Beth Israel Deaconess Medical Center, Boston

RECRUITING

Dana-Farber Cancer Institute, Boston

SUSPENDED

University Health Network-Princess Margaret Hospital, Toronto